Waldenstrom Macroglobulinemia

Showing NaN - NaN of 25

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Follicular Lymphoma Trial in United States (Zilovertamab vedotin)

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • +11 more
  • Zilovertamab vedotin
  • Duarte, California
  • +13 more
Jan 12, 2023

Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-cell Marginal Zone, Lymphoma, Non-Hodgkin Trial in Worldwide (LOXO-338,

Active, not recruiting
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • +6 more
  • Duarte, California
  • +8 more
Jan 11, 2023

Waldenstrom Macroglobulinemia, Multiple Myeloma, Chronic Lymphocytic Leukemia Trial in Worldwide (Iopofosine I 131 single dose,

Recruiting
  • Waldenstrom Macroglobulinemia
  • +8 more
  • Iopofosine I 131 single dose
  • +2 more
  • Redlands, California
  • +42 more
Dec 30, 2022

Waldenstrom Macroglobulinemia Trial in United States (Umbralisib)

Completed
  • Waldenstrom Macroglobulinemia
  • Washington, District of Columbia
  • +3 more
Oct 19, 2022

Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Lymphocytic, Small, Lymphoma, Mantle-Cell Trial in Worldwide (Pirtobrutinib)

Available
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • +4 more
  • Stanford, California
  • +61 more
Aug 17, 2022

Lymphoplasmacytic Lymphoma, Waldenstrom Macroglobulinemia Trial in United States (Ibrutinib, Rituximab, Venetoclax)

Suspended
  • Lymphoplasmacytic Lymphoma
  • Waldenstrom Macroglobulinemia
  • Centralia, Illinois
  • +73 more
Jul 27, 2022

Relapsed/Refractory B-cell Lymphomas, Diffuse Large B Cell Lymphoma (DLBCL), Follicular Lymphoma (FL) Trial in United States

Recruiting
  • Relapsed/Refractory B-cell Lymphomas
  • +11 more
  • CLBR001 and SWI019
  • Duarte, California
  • +7 more
Jul 26, 2022

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma Trial in Worldwide (Ibrutinib)

Enrolling by invitation
  • Chronic Lymphocytic Leukemia
  • +6 more
  • Duarte, California
  • +165 more
Mar 24, 2022

Waldenstrom Macroglobulinemia, Waldenstrom's Disease, Waldenström; Hypergammaglobulinemia Trial in New York (Ibrutinib,

Recruiting
  • Waldenstrom Macroglobulinemia
  • +6 more
  • New York, New York
    Weill Cornell Medicine
Dec 21, 2021

Multiple Myeloma, Waldenstrom Macroglobulinemia Trial in United States (oprozomib)

Terminated
  • Multiple Myeloma
  • Waldenstrom Macroglobulinemia
  • Scottsdale, Arizona
  • +18 more
Nov 15, 2021

Waldenstrom Macroglobulinemia Trial in New York (Epratuzumab (hLL2- anti-CD22 humanized antibody))

Terminated
  • Waldenstrom Macroglobulinemia
  • Epratuzumab (hLL2- anti-CD22 humanized antibody)
  • New York, New York
  • +1 more
Aug 12, 2021

Waldenström Macroglobulinemia Trial in United States (Zanubrutinib)

No longer available
  • Waldenström Macroglobulinemia
  • Mobile, Alabama
  • +19 more
Jun 8, 2021

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Lymphoplasmacytoid Lymphoma Trial in United States (SNS-062)

Terminated
  • Chronic Lymphocytic Leukemia
  • +7 more
  • Orange, California
  • +10 more
Oct 15, 2020

B-cell Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Diffuse Well-differentiated Lymphocytic Lymphoma Trial in

Completed
  • B-cell Chronic Lymphocytic Leukemia
  • +9 more
  • Stanford, California
  • +15 more
May 14, 2020

B Cell Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, Waldenstrom Macroglobulinemia Trial in United States (AVL-292)

Completed
  • B Cell Non-Hodgkin's Lymphoma
  • +2 more
  • Huntsville, Alabama
  • +12 more
Nov 6, 2019

Waldenstrom Macroglobulinemia Trial in New York (Thalidomide, Lenalidomide, Rituximab)

Terminated
  • Waldenstrom Macroglobulinemia
  • New York, New York
    Weill Cornell Medical College
Jun 13, 2018

Waldenström Macroglobulinemia Trial in Buffalo, New York (biological, drug, other)

Terminated
  • Waldenström Macroglobulinemia
  • ofatumumab
  • +2 more
  • Buffalo, New York
  • +1 more
May 3, 2016

Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in

Completed
  • Adult Nasal Type Extranodal NK/T-cell Lymphoma
  • +45 more
  • anti-endosialin/TEM1 monoclonal antibody MORAb-004
  • +2 more
  • Birmingham, Alabama
  • +19 more
Jan 7, 2016

Adult B Acute Lymphoblastic Leukemia, Chronic Lymphocytic Leukemia, Cutaneous B-Cell Non-Hodgkin Lymphoma Trial in United States

Terminated
  • Adult B Acute Lymphoblastic Leukemia
  • +28 more
  • Los Angeles, California
  • +6 more
Aug 18, 2015

Accelerated Phase Chronic Myelogenous Leukemia, Acute Leukemias of Ambiguous Lineage, Acute Myeloid Leukemia/Transient

Completed
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +50 more
  • Akt inhibitor MK2206
  • +2 more
  • Birmingham, Alabama
  • +24 more
Apr 28, 2014

Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic

Completed
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +84 more
  • sunitinib malate
  • +2 more
  • Los Angeles, California
  • +10 more
Mar 14, 2014

MALT, Nodal Marginal Zone B-cell Lymphoma, Prolymphocytic Leukemia Trial in New York (arsenic trioxide, laboratory biomarker

Terminated
  • Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
  • +10 more
  • arsenic trioxide
  • laboratory biomarker analysis
  • New York, New York
    Mount Sinai Medical Center
Jan 31, 2013